All 6 relapsed patients were detected MLL-PTD positive prior to relapse, while only 4 patients were detected positive for WT1. As shown in Table 2, the expression levels of MLL-PTD and WT1 both changed with the tumor burden. This evidence concerns the gene WT1 and neoplasm.